Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents

Molecular and Cellular Biochemistry

Volumn 153, Issue 1-2, 1995, Pages 17-24

  Crans, Debbie C ^a   Mahroof Tahir, Mohammed ^a   Keramidas, Anastasios D ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

Author keywords

compound lability; compound stability; insulin mimetic; metabolic involvement; vanadium biochemistry; vanadium chemistry

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; VANADIC ACID; VANADIUM DERIVATIVE;

CHEMICAL ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DECOMPOSITION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; OXIDATION REDUCTION STATE;

HYPOGLYCEMIC AGENTS; OXIDATION-REDUCTION; VANADIUM; VANADIUM COMPOUNDS;

ANIMALIA;

EID: 0029582783     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/BF01075914     Document Type: Article

References (46)

1. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes
2. Insulin mimetic agents: Vanadium and peroxovanadium compounds
3. Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes
4. Vanadium compounds as insulin mimics
5. Teroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics
6. Enzyme interactions with labile oxovanadates and other oxometalates
7. Inhibition of phosphatemetabolizing enzymes by oxovanadium complexes
8. Stimulation of enzyme activity by oxovanadium complexes
9. The interaction of vanadate with tyrosine kinases and phosphatases
10. Role of vanadium in biology
11. Vanadium in the biosphere
12. Vanadium(V) oxyanions: The esterification of ethanol with vanadate
13. Vanadium(V) oxyanions: The interaction of vanadate with pyrophosphate, phosphate, and arsenate
14. Glutatione reduces cytoplasmic vanadate; mechanism and physiological implications
15. Reduction of vanadate(V) to oxovanadium(IV) by cysteine and mechanism and structure of the oxovanadium(IV)-cysteine complex subsequently formed
16. 4th: Vanadium and other metal ions in the physiological ecology of marine orgarismus
17. Characterization of the binding, kinetics, and redox stability of vanadium(IV) and vanadium(V) protein complexes in serum
18. Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae
19. The fate of cytoplasmic vanadium
20. Vanadyl(IV) EPR spin probes inorganic and biochemical aspects
21. Chemically induced modification of cofactor specificity of glucose-6-phosphate dehydrogenase
22. Vanadate-stimulated oxidation of NAD(P)H in the presence of biological membranes and other sources of O2−
23. Interaction of inorganic vanadate with glucose-6-phosphate dehydrogenase. Nonenzymic formation of glucose-6-vanadate
24. Reversible and in situ formation of organic arsenates and vanadates as organic phosphate mimics in enzymatic reactions: Mechanistic investigation of aldol reactions and synthetic applications
25. Possible transition-state analogs for ribonuclease. The complexes of uridine with oxovanadium(IV) ion and vanadium(V) ion
26. Characterization of a vanadate-based transition-state-analogue complex of phosphoglucomutase by kinetic and equilibrium binding studies. Mechanistic implications
27. Inhibition of phosphoglucomutase by vanadate
28. Inhibition of myosin ATPase by vanadate ion
29. Detergent-induced distinctions between fluoride- and vanadate-stimulated adenylate cyclases and their responses to guanine nucleotides
30. Vanadium ion inhibition of alkaline phosphatase-catalyzed phosphate ester hydrolysis
31. Peroxide(s) of vanadium: A novel and potent insulin-mimetic agent which activates the insulin receptor kinase
32. Studies on peroxovanadates. I. The crystal structure of ammonium μoxo-bis(oxodiperoxovanadate(V)), (NH4)4[O(VO(O2)2)2]
33. Insulin-mimetic peroxovanadium complexes: Preparation and structure of potassium oxodiperoxo(pyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(C5H4NCOO)]·2H2O, and potassium oxodiperoxo(3-hydroxypyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(OHC5H3NCOO)]·3H2O, and their reactions with cysteine
34. Preparation and characterization of dipicolinatovanadium(V) complexes: Kinetics and mechanism of their reaction with hydrogen peroxide in acidic media
35. Bis(maltolato)-oxovanadium(IV) is a potent insulin mimic
36. Komplexe XXXVII. Die EDTA-komplexe des vanadiums(V)
37. Oxoperoxo(citrato)- and dioxo-(citrato)vanadates(V): Synthesis, spectra, and structure of a hydroxyl oxygen bridged dimer, K2[VO(O2)(C6H6O7)]2·2H2O
38. Tetrameric dioxo(oxalato)-vanadates(V). The crystal structure of K[VO2(C2O4)2]2·H2O
39. Aqueous chemistry of labile oxovanadates: Of relevance to biological studies
40. Applicadon of dme-resolved51V 2D NMR for quantitation of kinede exchange pathways between vanadate monomer, dimer, tetramer, and pentamer
41. Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate
42. Photochemical oxidation of hydrocarbons by vanadium(v)peroxo complex
43. Nature of the radical intermediates in the decomposition of peroxovanadium species in protic and aprotic media
44. Structural and kinetic characterization of simple complexes as models for vanadate-protein interactions
45. Application of NMR spectroscopy to studies of aqueous coordination chemistry of vanadium(V) complexes